Evidence map›Paper›PMID 25584079›Full record

ArticleJournal of chemical biology2015

Mitochondrial protein alterations in a familial peripheral neuropathy caused by the V144D amino acid mutation in the sphingolipid protein, SPTLC1.

Scott E Stimpson, Jens R Coorssen, Simon J Myers

Abstract read
In one paragraph

Article in Journal of chemical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Scott E StimpsonNeuro-Cell Biology Laboratory, University of Western Sydney, Penrith, Australia ; Molecular Medicine Research Group, University of Western Sydney, Penrith, Australia ; School of Science and Health, University of Western Sydney, Penrith, Australia.
Jens R CoorssenMolecular Physiology, University of Western Sydney, Penrith, Australia ; Molecular Medicine Research Group, University of Western Sydney, Penrith, Australia ; School of Science and Health, University of Western Sydney, Penrith, Australia ; School of Medicine, University of Western Sydney, Locked Bag 1797, Penrith, NSW 2751 Australia ; School of Medicine, University of Western Sydney, Office 30.2.15, Campbelltown campus, Locked Bag 1797, Penrith, NSW 2751 Australia.
Simon J MyersNeuro-Cell Biology Laboratory, University of Western Sydney, Penrith, Australia ; Molecular Medicine Research Group, University of Western Sydney, Penrith, Australia ; School of Science and Health, University of Western Sydney, Penrith, Australia ; School of Medicine, University of Western Sydney, Locked Bag 1797, Penrith, NSW 2751 Australia ; University of Western Sydney, Office 21.1.05, Campbelltown campus, Locked Bag 1797, Penrith, NSW 2751 Australia.
Western Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Axonal degeneration is the final common path in many neurological disorders. Subsets of neuropathies involving the sensory neuron are known as hereditary sensory neuropathies (HSNs). Hereditary sensory neuropathy type I (HSN-I) is the most common subtype of HSN with autosomal dominant inheritance. It is characterized by the progressive degeneration of the dorsal root ganglion (DRG) with clinical symptom onset between the second or third decade of life. Heterozygous mutations in the serine palmitoyltransferase (SPT) long chain subunit 1 (SPTLC1) gene were identified as the pathogenic cause of HSN-I. Ultrastructural analysis of mitochondria from HSN-I patient cells has displayed unique morphological abnormalities that are clustered to the perinucleus where they are wrapped by the endoplasmic reticulum (ER). This investigation defines a small subset of proteins with major alterations in abundance in mitochondria harvested from HSN-I mutant SPTLC1 cells. Using mitochondrial protein isolates from control and patient lymphoblasts, and a combination of 2D gel electrophoresis, immunoblotting and mass spectrometry, we have shown the increased abundance of ubiquinol-cytochrome c reductase core protein 1, an electron transport chain protein, as well as the immunoglobulin, Ig kappa chain C. The regulation of these proteins may provide a new route to understanding the cellular and molecular mechanisms underlying HSN-I.

Indexed as

Hereditary sensory neuropathy type 1MitochondriaSerine palmitoyltransferase long chain subunit 1Ubiquinol-cytochrome c reductase core protein 1

Identifiers

PMID25584079
PMCPMC4286568
OpenAlexW1996738720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.